Literature DB >> 8102644

Role of NMDA and non-NMDA receptors in the nucleus tractus solitarius in the depressant effect of ethanol on baroreflexes.

M M el-Mas1, A A Abdel-Rahman.   

Abstract

Ethanol has been shown to attenuate hemodynamic responses to baroreceptor activation. Because the excitatory amino acid (EAA), L-glutamate (L-Glu), modulates the baroreceptor function within the nucleus tractus solitarius (NTS), the present study investigated whether ethanol-evoked impairment of baroreceptor activity involves blockade of EAA receptors in this area and whether this action involves selective blockade of N-methyl-D-aspartate (NMDA) receptors. Separate groups of urethane-anesthetized Sprague-Dawley rats received graded doses of the EAA receptor agonists, L-Glu, NMDA, kainic acid or alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid microinjected into the NTS before and after systemic administration of ethanol (1 g/kg). Baroreflex-mediated heart rate responses (baroreflex sensitivity, BRS) were tested by phenylephrine in the same rats. Different doses of the agonists were selected so that comparable dose-related depressor and bradycardic responses were obtained. Ethanol significantly attenuated the BRS and the hemodynamic responses elicited by all EAA agonists. However, the attenuation of the hemodynamic responses was more evident with NMDA. This effect was dose related because a dose of 0.1 g/kg of ethanol had no effect on either BRS or hemodynamic responses to NMDA. Whether systemic ethanol attenuated these responses by a peripheral action or interaction with other brain areas that receive input from the NTS was investigated. Microinjection of ethanol (10 micrograms) into the NTS significantly attenuated the BRS and the hemodynamic responses elicited by NMDA microinjected into the same site. In contrast, responses elicited by non-NMDA (kainic acid and alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid) agonists were preserved.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102644

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

2.  Role of rostral ventrolateral medullary ERK/JNK/p38 MAPK signaling in the pressor effects of ethanol and its oxidative product acetaldehyde.

Authors:  Mahmoud M El-Mas; Ming Fan; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2013-07-26       Impact factor: 3.455

3.  Bradykinin B2 receptor-dependent enhancement of enalapril-evoked hypotension in ethanol-fed female rats.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2011-01       Impact factor: 3.105

4.  Ethanol attenuates peripheral NMDAR-mediated vascular oxidative stress and pressor response.

Authors:  Marie A McGee; Abdel A Abdel-Rahman
Journal:  Alcohol       Date:  2015-04-28       Impact factor: 2.405

5.  Ser/thr phosphatases tonically attenuate the ERK-dependent pressor effect of ethanol in the rostral ventrolateral medulla in normotensive rats.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Brain Res       Date:  2014-06-28       Impact factor: 3.252

Review 6.  N-Methyl-D-Aspartate Receptor Signaling and Function in Cardiovascular Tissues.

Authors:  Marie A McGee; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2016-08       Impact factor: 3.105

7.  Acute ethanol modulation of neurocircuit function in the nucleus of the tractus solitarius.

Authors:  Michael A Aimino; Caitlin R Coker; Yuval Silberman
Journal:  Brain Res Bull       Date:  2017-07-29       Impact factor: 4.077

8.  Ethanol and opioids do not act synergistically to depress excitation in carotid body type I cells.

Authors:  Ryan Rakoczy; Kajal Kamra; Yoon-Jae Yi; Christopher Wyatt
Journal:  Neuroreport       Date:  2021-11-02       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.